INTRODUCTION: Studies of advance care planning (ACP) completion rates in HIV-infected persons pre-date the "graying" of the HIV epidemic. We sought to examine current ACP completion rates and factors influencing completion among HIV-infected persons. METHODS: HIV-1-seropositive persons aged 45-65 years on effective antiretroviral therapy for a minimum of 6 months were enrolled in a cross-sectional survey. Likelihood of ACP was assessed by demographic and clinical characteristics, tested with odds ratios (OR) and 95% Wald confidence intervals (CI), and adjusted for gender. RESULTS: Of 238 participants, 112 (47%) completed ACP. Persons ≥55 years of age (OR 2.8; CI 1.6,5.0; p<0.001), males (OR 4.1; CI 1.8,9.3; p=0.004), and persons with higher education (OR 2.2; CI 1.3,4.0; p=0.007) were more likely to have completed ACP. Persons with a cardiac event were more likely to have completed ACP (OR 5.5; CI 1.6,25; p=0.03), although this effect was diminished after adjusting for gender (OR 4.5; CI 0.95,21.4; p=0.06). HIV infection diagnosed for greater than 5 years was not associated with ACP completion (OR 1.3; CI 0.7,2.7; p=0.4). Current CD4(+) cell counts were similar between those completing and not completing documentation (588 cells/μL and 604 cells/μL, respectively; p=0.7). The likelihood of ACP did not significantly differ with other comorbidities. DISCUSSION: Less than 50% of middle-aged patients in HIV care had documented ACP. In particular, women and those with lower education were at greatest risk of non-completion and may need interventions to improve ACP.
INTRODUCTION: Studies of advance care planning (ACP) completion rates in HIV-infectedpersons pre-date the "graying" of the HIV epidemic. We sought to examine current ACP completion rates and factors influencing completion among HIV-infectedpersons. METHODS:HIV-1-seropositive persons aged 45-65 years on effective antiretroviral therapy for a minimum of 6 months were enrolled in a cross-sectional survey. Likelihood of ACP was assessed by demographic and clinical characteristics, tested with odds ratios (OR) and 95% Wald confidence intervals (CI), and adjusted for gender. RESULTS: Of 238 participants, 112 (47%) completed ACP. Persons ≥55 years of age (OR 2.8; CI 1.6,5.0; p<0.001), males (OR 4.1; CI 1.8,9.3; p=0.004), and persons with higher education (OR 2.2; CI 1.3,4.0; p=0.007) were more likely to have completed ACP. Persons with a cardiac event were more likely to have completed ACP (OR 5.5; CI 1.6,25; p=0.03), although this effect was diminished after adjusting for gender (OR 4.5; CI 0.95,21.4; p=0.06). HIV infection diagnosed for greater than 5 years was not associated with ACP completion (OR 1.3; CI 0.7,2.7; p=0.4). Current CD4(+) cell counts were similar between those completing and not completing documentation (588 cells/μL and 604 cells/μL, respectively; p=0.7). The likelihood of ACP did not significantly differ with other comorbidities. DISCUSSION: Less than 50% of middle-aged patients in HIV care had documented ACP. In particular, women and those with lower education were at greatest risk of non-completion and may need interventions to improve ACP.
Authors: N S Wenger; D E Kanouse; R L Collins; H Liu; M A Schuster; A L Gifford; S A Bozzette; M F Shapiro Journal: JAMA Date: 2001-06-13 Impact factor: 56.272
Authors: Karen B Hirschman; Katherine M Abbott; Alexandra L Hanlon; Janet Prvu Bettger; Mary D Naylor Journal: J Am Med Dir Assoc Date: 2011-02-26 Impact factor: 4.669
Authors: G P Eleazer; C A Hornung; C B Egbert; J R Egbert; C Eng; J Hedgepeth; R McCann; H Strothers; M Sapir; M Wei; M Wilson Journal: J Am Geriatr Soc Date: 1996-08 Impact factor: 5.562
Authors: J S Haas; J S Weissman; P D Cleary; J Goldberg; C Gatsonis; G R Seage; F J Fowler; M P Massagli; H J Makadon; A M Epstein Journal: Arch Intern Med Date: 1993-05-24
Authors: Lawrence S Wissow; Amy Belote; Wade Kramer; Amy Compton-Phillips; Robert Kritzler; Jonathan P Weiner Journal: J Gen Intern Med Date: 2004-09 Impact factor: 5.128
Authors: Heather Heiman; David W Bates; David Fairchild; Shimon Shaykevich; Lisa Soleymani Lehmann Journal: Am J Med Date: 2004-09-01 Impact factor: 4.965
Authors: Karen Nieves-Lugo; Deanna Ware; M Reuel Friedman; Sabina Haberlen; James Egan; Andre L Brown; Omar Dakwar; Michael Plankey Journal: AIDS Care Date: 2019-09-23
Authors: Katherine B Grill; Jichuan Wang; Rachel K Scott; Debra Benator; Lawrence J D'Angelo; Maureen E Lyon Journal: Am J Hosp Palliat Care Date: 2021-01-19 Impact factor: 2.090
Authors: Christiana Bitas; Sian Jones; Harjot Kaur Singh; Mildred Ramirez; Eugenia Siegler; Marshall Glesby Journal: J Int Assoc Provid AIDS Care Date: 2019 Jan-Dec
Authors: Jerel Fields; Wilmar Dumaop; Edward Rockenstein; Michael Mante; Brian Spencer; Igor Grant; Ron Ellis; Scott Letendre; Christina Patrick; Anthony Adame; Eliezer Masliah Journal: J Neurovirol Date: 2013-01-24 Impact factor: 2.643
Authors: Mona Abdo; Adam Ressler; Samantha MaWhinney; Catherine Jankowski; Steven C Johnson; Kristine M Erlandson Journal: J Assoc Nurses AIDS Care Date: 2021 Jan-Feb 01 Impact factor: 1.809